BioNJ Thanks Our Renewing Members:

BioNJ thanks our renewing Preferred Members: EisnerAmper, LLP EisnerAmper’s Life Sciences Practice professionals have the expertise, resources and relationships to assist both public and private life sciences companies bridge the gap between business and science. In addition to the traditional tax and accounting services, Amper also assists our life sciences clients with services spanning the… Read the full article


BioNJ welcomes our new Associate Members

BioNJ welcomes our new Associate Members: Borderless Executive Search, Inc. Borderless Executive Search, Inc. is an international executive search and leadership consulting firm specializing in life sciences (pharma, biotech and medtech). Founded in 2000, we take an innovative, consultative and seamless approach to trans-national executive search. We operate as one global team, working across cultures… Read the full article


BioNJ welcomes our new Innovation Members

BioNJ welcomes our new Innovation Members: Acuta Pharmaceuticals, LLC Aucta Pharmaceuticals, LLC is founded by experienced pharmaceutical research scientists from the U.S. and China, and managed by U.S. pharma industry veterans, with locations in Shanghai, China and New Jersey. Our expertise is new drug product development, product label improvement and solving difficult technical issues. We… Read the full article


BioNJ welcomes our new Institutional Members

BioNJ welcomes our new Institutional Member: Cambridge Crystallographic Data Centre The Cambridge Crystallographic Data Centre (CCDC) is a crystallographic organization based in Cambridge, England. It is a non-profit organization whose primary role is the compilation and maintenance of the Cambridge Structural Database, a database of small molecule crystal structures. We also perform analysis on the… Read the full article


Senate Health, Human Services and Senior Citizens Committee Approves Biosimilars Legislation Unanimously

TRENTON, NJ (June 9, 2015) – Legislation that allows for greater Patient access to more affordable FDA-approved biologic medicines was approved unanimously by the Senate Health, Human Services and Senior Citizens Committee. The bill now moves to review by the full Senate. “This legislation, over a year in the making, represents a thoughtful, balanced approach to… Read the full article


Weekender 6/5/15

To Our New Jersey Life Sciences Community: Welcome to another edition of the Weekender. New Jersey Companies Continue Progress in Drug Development Edge Therapeutics, a BioNJ Member located in Berkeley Heights, announced that the U.S. Food and Drug Administration has granted orphan drug designation to EG-1962, the Company’s lead product candidate, which is in clinical… Read the full article


Weekender 5/29/15

To Our New Jersey Life Sciences Community: Welcome to another edition of the Weekender. Congratulations to four New Jersey companies that received Food and Drug Administration (FDA) approvals. These wonderful accomplishments shine a positive light on the dynamic life sciences ecosystem in New Jersey. We can’t wait to share more of your positive news throughout… Read the full article


Weekender 5/22/15

To Our New Jersey Life Sciences Community: Welcome to another edition of The Weekender. Federal Research Bill Holds Promise for ‘Personalized Medicine’ in New Jersey The House Energy and Commerce Committee unanimously approved the 21st Century Cures Act, 51-0. The legislation has earned rave reviews across New Jersey’s research community, as well as its biotechnology and… Read the full article


Weekender 5/15/15

To Our New Jersey Life Sciences Community: Welcome to another edition of The Weekender. It’s Been a Banner Week for the New Jersey Life Sciences Community At the State level, Biosimilars legislation (A2477) was approved by the Assembly in a unanimous vote (72-0). This legislation allows pharmacists to substitute biosimilar products as long as the… Read the full article


Unanimous Approval of A2477 – Making Biological Drug Alternatives More Widely Available

TRENTON, NJ (May 14, 2015) — BioNJ, The Gateway to Health, is pleased with the passage of A2477, legislation that will allow greater Patient access to more affordable FDA-approved biologic medicines. Biological medicines are vital to the treatment of conditions such as cancer, diabetes, infectious diseases and a variety of immune disorders. BioNJ’s rallying cry… Read the full article